Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Dr Reddy’s Laboratories Ltd (REDY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6,038.00 +28.00    +0.47%
05:58:43 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE089A01023 
S/N:  DRREDDY
  • Volume: 9,158
  • Bid/Ask: 6,052.00 / 6,060.00
  • Day's Range: 5,987.00 - 6,071.00
Dr Reddy’s Laboratories 6,038.00 +28.00 +0.47%

Dr Reddy’s Laboratories Ltd Company Profile

 
Get an in-depth profile of Dr Reddy’s Laboratories Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

25863

Equity Type

ORD

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company’s Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Contact Information

Address 8-2-337, Road No. 3 Banjara Hills
Hyderabad, 500034
India
Phone 91 40 4900 2900
Fax 91 40 4900 2999

Top Executives

Name Age Since Title
Kallam Satish Reddy 54 1993 Chairman of the Board & Member of the Management Council
Gunupati Venkateswara Prasad 61 1986 Co-Chairman, MD & Member of Management Council
Kalpana Jaisingh Morparia 74 2007 Lead Independent Director
Shikha Sanjaya Sharma 65 2019 Additional Independent Director
Claudio Albrecht - 2023 Director
Kodumudi Pranatharthiharan Krishnan 64 2022 Additional Independent Director
K. Janardhan Reddy - - Member of the Scientific Advisory Board
R. Rajgopalan 73 2001 Member of the Scientific Advisory Board
Arun Madhavan Kumar - 2022 Independent Director
Leo Puri 63 2018 Independent & Non Whole-time Director
Penny Wan 57 2022 Additional Independent Director
Alpna H. Seth 60 2023 Independent Director
Sanjiv Mehta 64 2023 Additional Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

REDY Comments

Write your thoughts about Dr Reddy’s Laboratories Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Amit Gautam
Amit Gautam Aug 23, 2023 9:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it should be down
Loveneet Kumar
Loveneet Kumar Aug 09, 2023 2:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
insider tader wait
Loveneet Kumar
Loveneet Kumar Aug 09, 2023 1:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
don't be pennic
Loveneet Kumar
Loveneet Kumar Aug 09, 2023 1:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wait dear all because it's achievement is coming so buy more
Loveneet Kumar
Loveneet Kumar Aug 09, 2023 1:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
govt official announcement with in two hours because some formalities are permitting
Loveneet Kumar
Loveneet Kumar Aug 09, 2023 1:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
everyone who is invested in the stock please hold the position till stock is not touch 5000 thanks a lot
Loveneet Kumar
Loveneet Kumar Aug 09, 2023 1:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
market regulator sebi also take action on Dr reddy for insider trading so stock may corrected today
Loveneet Kumar
Loveneet Kumar Aug 09, 2023 1:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
moddy downgrade the Dr reddy about earning concern
jenti jokham
jenti jokham Jul 05, 2023 1:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
may be 5600 after couple of months. no worries. I liked that proposition. infact let's keep it 7200 after 2 years.. 👍
jenti jokham
jenti jokham Jul 05, 2023 1:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
5600??
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email